ART-446

N/A

Report date: 2024/07/08 13:49:17
NME

Base Information

Drug NameART-446
Drug Alias NameART-446
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 2 inhibitors
TargetsCheckpoint kinase 2
Therapy Area/IndicationsColonic NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColonic NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A